Aurobindo Pharma is setting up a new laboratory to test oncology products, it was announced today.
Managing director Frederick Schembri said that on the tenth anniversary of the company, they were announcing a new investment in setting up a new laboratory to test oncology related products.
This is a new sector for the company, he said, adding that the Maltese operator will be responsible for testing medicine for the EU market. The investment will cost €3 million, he said, and will see 20 new jobs created.
Prime Minister Joseph Muscat today visited Aurobindo Pharma, and said that Aurobindo is the 12th largest producer of generic medication in the world. He said that in Malta, it grew from a small office, and now employs 150 people in Malta.
Muscat said that through the company's investment, medicines tested in their laboratories make their way to EU and African markets